Scientists unveil synthetic cells to power low-carbon factories - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Scientists unveil synthetic cells to power low-carbon factories

Invention known as SpudCell is part of effort to use micro-scale bioengineering in manufacture of everyday items
00:00

{"text":[[{"start":7.7,"text":"Scientists have unveiled synthetic cells aimed at revolutionising industrial production by serving as tiny biological factories to make environmentally friendly materials for goods from drugs to plastics."}],[{"start":19.9,"text":"The new invention known as SpudCell will be made available to researchers around the world, as part of an expanding effort to put micro-scale bioengineering at the heart of lower-carbon manufacturing for everyday items.SpudCell is the first synthetic system to achieve a complete cell cycle of feeding, growth and reproduction, according to a paper released on Wednesday but not yet peer-reviewed. It is built from the bottom up using known non-living chemical components, as opposed to previous methods based on pared-down living cells and their naturally occurring parts."}],[{"start":54.4,"text":"The discovery highlights how progress in synthetic biology is opening dramatic new possibilities for turning cells from existing life forms and human-made variations on them into miniature workshops. The advances have intensified debate over how the powerful technologies should be owned and regulated, particularly if it one day becomes possible to make living organisms in laboratories.Bioengineered microbes are already used as miniature factories to make products such as insulin and biodegradable plastics. The consultancy McKinsey estimated in 2023 that 400 use cases of bioengineering more widely, almost all of them scientifically feasible, could have an annual economic impact of $2tn to $4tn from 2030 to 2040."}],[{"start":103.05,"text":"“We need to be able to manufacture things in a way that doesn’t harm the planet and in a way that’s actually renewable,” said Kate Adamala, leader of the SpudCell project and a University of Minnesota scientist. “We have enough atoms on this planet. We just need to move those atoms in a way that’s more sustainable — and also politically more decentralised.”"}],[{"start":122.55,"text":"“This is the first time the full cycle of a living cell has been run in a system that was built, not born — assembled from scratch rather than scaled down from something already alive,” the researchers said, noting that SpudCells could in principle be custom-built to make a variety of products. “This work opens up entire fields, and could ultimately underlie new therapeutics, materials, foods and approaches to carbon removal in the long-term future.”"}],[{"start":147.5,"text":"SpudCell still had several areas of scope for improvement, the scientists said. These include reducing its dependence on external food sources, increasing the sophistication of its reproduction mechanisms and building its own capacity to manufacture proteins."}],[{"start":162.45,"text":"The patent to SpudCell is owned by the University of Minnesota and exclusively licensed to Biotic, a US-based non-profit organisation with the stated aim of promoting the collaborative building of vital synthetic cell infrastructure. The researchers compare Biotic’s ambition to how the Human Genome Project was aimed at ensuring a “critical piece of human heritage” should “become a common scientific tool”."}],[{"start":187.64999999999998,"text":"The SpudCell work “opens the door to being able to have a simple system that can be asked to produce specific things at scale”, said Roseanna Zia, a University of Missouri engineering professor and expert on the modelling of biological cells.  "}],[{"start":202.89999999999998,"text":"Efforts by Biotic and other researchers could help ensure synthetic cell technology was not “locked up in patents that would allow only big companies to take advantage”, said John Glass, leader of the synthetic biology group at the J Craig Venter Institute."}],[{"start":218.74999999999997,"text":"“I think synthetic biology and synthetic cells can go a long way towards solving many of the world’s economic, medical, environmental and industrial problems,” Glass said. “Open-source or some version of open-source technology is the best way to make this happen.”"}],[{"start":235.84999999999997,"text":"Advances in bioengineering have stoked concerns about the potential for technologies to cause harm to living organisms, either through accidental leaks or deliberate targeting.  "}],[{"start":245.69999999999996,"text":"SpudCell cannot survive outside controlled laboratory conditions and so presents only a remote risk of use as a bioweapon, its creators argue."}],[{"start":255.24999999999997,"text":"Good governance of the development of synthetic cell technology was vital given the dangers posed by hackers and other bad actors, said Juan Pérez-Mercader, a senior research fellow at Harvard University’s Origins of Life Initiative."}],[{"start":268.79999999999995,"text":"“Guards must be placed lest we affect in irreversible ways the evolution of natural life,” Pérez-Mercader said. “Biotic could be a great first step in the direction of fostering the research and promoting necessary engineering standards and ethics.” "}],[{"start":291.29999999999995,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1783086940_7915.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

AI股票泡沫终于要破裂了吗?

马丁:任何理性的人都能看出AI资产中不可持续的迹象。

埃森哲与“四大”瞄准中型企业市场谋增长

随着AI释放人力、降低服务成本,咨询巨头纷纷将目光投向规模较小的企业,希望以更低价格提供服务。

法拉奇:“我从未支持无休止的战争”

英国改革党领导人在美国共和党中期选举惨败后淡化了自己对伊朗战争的支持。

“蓝色浪潮”对美国经济变革的期待恐将落空

艾肯格林:美国国会的党派构成发生变化,对特朗普剩余任期内的政策制定影响不大。

民主党横扫中期选举,华尔街大金主押注失利

顶级对冲基金经理和私募股权投资公司高管为共和党竞选活动投入逾3亿美元,却几乎未见成效。
19小时前

美国的清晨,市场的黄昏

罗奇:美国中期选举结果再令人震惊,也阻止不了经济金融周期的转向。
设置字号×
最小
较小
默认
较大
最大
分享×